Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Emtricitabine:Susc:Pt:Isolate:OrdQn:Phenotyping

Known as: Emtricitabine:Susc:Pt:Isolado:OrdQn:Fenotipagem, Emtricitabine:Gevoeligheid:Moment:Isolaat:OrdinaalKwantitatief:Fenotypering, Emtrisitabin:Duyr:Zml?:?zolat:SrlKant:Fenotipleme 
 
National Institutes of Health

Related topics

Related topics

3 relations
Isolate - microorganismPhenotype determinationemtricitabine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir
Pregnancy is associated with physiological changes that may impact drug pharmacokinetics (PK). The goals of this study were to… Expand
2015
2015
Viral and inflammatory markers in cerebrospinal fluid of patients with HIV‐1‐associated neurocognitive impairment during antiretroviral treatment switch
The aim of the study was to evaluate HIV‐1 viral load (VL) and inflammatory markers in cerebrospinal fluid (CSF) and… Expand
Review
2012
Review
2012
A Review of the Virological Efficacy of the 4 World Health Organization–Recommended Tenofovir-Containing Regimens for Initial HIV Therapy
We systematically reviewed the first-line tenofovir regimens recommended in the 2010 World Health Organization Antiretroviral… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
2005
2005
Antiviral response and resistance surveillance for HBeAgnegative patients enrolled in a combination study evaluatingemtricitabine plus clevudine versus emtricitabine monotherapyfor the treatment of…
 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE